Roles of cyclin D1 and related genes in growth inhibition, senescence and apoptosis

Apoptosis

Volumn 4, Issue 3, 1999, Pages 213-219

  Han, E K H ^a,b   Ng, S C ^b   Arber, N ^a   Begemann, M ^a   Weinstein, I B ^a  

^a New York Presbyterian Columbia University Medical Center   (United States)

^b ABBOTT LABORATORIES   (United States)

Author keywords

Apoptosis; Cyclin D1; Growth inhibition; Senescence

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE INHIBITOR; PROTEIN P21; PROTEIN P27; PROTEIN P53;

ANIMAL CELL; APOPTOSIS; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL GROWTH; CELL PROLIFERATION; GROWTH INHIBITION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; REVIEW; SENESCENCE;

ANIMALIA;

EID: 0032806092     PISSN: 13608185     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1009618824145     Document Type: Review

References (74)

1. Harper JW. Cyclin dependent kinase inhibitors. Cancer Surveys 1997; 29: 91-107.
2. Hunter T, Pines J. Cyclins and cancer II: Cyclin D1 and CDK inhibitors come of age. Cell 1994; 79: 573-582.
3. Reed SI. Control of the G1/S transition. Cancer Surveys 1997; 29: 7-23.
4. Sherr CJ. G1 phase progression: cycling on cue. Cell 1994; 79: 551-555.
5. Sherr CJ, Roberts JM. Mammalian cyclin-dependent kinase inhibitors. Genes & Dev 1995; 9: 1149-1163.
6. Dou QP. Putative roles of retinoblastoma protein in apoptosis. Apoptosis 1997; 2: 5-18.
7. Evan GI, Brown L, Whyte M, Harrington E. Apoptosis and the cell cycle. Curr Op Cell Bio 1995; 7: 825-834.
8. King KL, Cidlowski JA. Cell cycle regulation and apoptosis. Annu Rev Physiol 1998; 60: 601-617.
9. Meikrantz W, Schlegel R. Apoptosis and the cell cycle. J Cell Biochem 1995; 58: 160-174.
10. Muschel RJ, Mckenna WG, Bernhard EJ. Cell cycle checkpoints and apoptosis: potential for improving radiation therapy. Vitamins and Hormones 1997; 53: 1-25.
11. kip1, inhibits growth, and enhances apoptosis. Cell Growth Diff 1996; 7: 699-710.
12. Weinstein IB, Begemann M, Zhou P, et al. Disorders in cell circuitry associated with multistage carcinogenesis: exploitable targets for cancer prevention and therapy. Clin Cancer Res 1997; 3: 2696-2702.
13. Kranenburg O, van der Eb AJ, Zantema A. Cyclin D1 is an essential mediator of apoptotic neuronal cell death. EMBO J 1996; 15: 46-54.
14. Sofer-Levi Y, Resnitzky D. Apoptosis induced by ectopic expression of cyclin D1 but not cyclin E. Oncogene 1996; 13: 2431-2437.
15. Jiang W, Kahn SM, Zhou P, et al. Overexpression of cyclin D1 in rat fibroblasts causes abnormalities in growth control, cell cycle progression and gene expression. Oncogene 1993; 8: 3447-3457.
16. Quelle DE, Ashmun RA, Shurtleff SA, et al. Overexpression of mouse D1-type cyclins accelerates G1 phase in rodent fibroblasts. Genes & Dev 1993; 7: 1559-1571.
17. Resnitzky D, Gossen M, Bujard H, Reed SI. Acceleration of the G1/S phase transition by expression of cyclins D1 and E with an inducible system. Mol Cell Biol 1994; 14: 1669-1679.
18. Hinds PW, Dowdy SF, Eaton EN, Arnold A, Weinberg RA. Function of a human cyclin gene as an oncogene. Proc NatlAcad Sci USA 1994; 91: 709-713.
19. Lovec H, Sewing A, Lucibello FC, Muller R, Moroy T. Oncogenic activity of cyclin D1 revealed through cooperation with Ha-ras: Link between cell cycle control and malignant transformation. Oncogene 1994; 9: 323-326.
20. Afar DE, McLaughlin J, Sherr CJ, Witte ON, Roussel MF. Signaling by ABL oncogenes through cyclin D1. Proc Natl Acad Sci USA 1995; 92: 9540-9544.
21. Resnitzky D. Ectopic expression of cyclin D1 but not cyclin E induces anchorage-independent cell cycle progression. Mol Cell Biol 1997; 17: 5640-5647.
22. Arber N, Doki Y, Han EK-H, et al. Antisense to cyclin D1 inhibits the growth and tumorigenicity of human colon cancer cells. Cancer Res 1997; 57: 1569-1574.
23. Zhou P, Jinag W, Zhang YJ, et al. Antisense to cyclin D1 inhibits growth and reverses the transformed phenotype of human esophageal cancer cells. Oncogene 1995; 11: 571-580.
24. Wang TC, Cardiff RD, Zukerberg L, Lees E, Arnold A, Schmidt EV. Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature 1994; 369: 669-671.
25. Fantl V, Stamp G, Andrews A, Rosewell I, Dickson C. Mice lacking cyclin D1 are small and show defects in eye and mammary gland development. Genes Dev 1997; 9: 2364-2372.
26. Sicinski P, Donaher JL, Geng Y, et al. Cyclin D1 provides a link between development and oncogenesis in the retina and breast. Cell 1995; 82: 621-630.
27. Neuman E, Ladha MH, Lin N, et al. Cyclin D1 stimulation of estrogen receptor transcriptional activity independent of cdk4. Mol Cell Biol 1997; 17: 5338-5347.
28. Zwijsen RM, Wientjens E, Klompmaker R, van der Sman J, Bernards R, Michalides RJ. CDK-independent activation of estrogen receptor by cyclin D1. Cell 1997; 88: 405-415.
29. Motokura T, Bloom T, Kim HG, et al. A novel cyclin encoded by a bcl-linked candidate oncogene. Nature 1991; 350: 512-515.
30. Rosenberg CL. PRAD1, acandidate BCL1 oncogene: mapping and expression in centrocytic lymphoma. Proc Natl Acad Sci USA 1991; 88: 9638-9642.
31. Withers DA, Harvery RC, Faust JB, Melnyk O, Carey K, Meeker TC. Characterization of a candidate bcl-1 gene. Mol Cell Biol 1991; 11: 4846-4853.
32. Han EKH, Lim JTE, Arber N, Rubin MA, Xing WQ, Weinstein IB. Cyclin D1 expression in human prostate carcinoma cell lines and primary tumors. Prostate 1998; 35: 95-101.
33. Bartkova J, Lukas J, Muller H, Lutzhoft D, Strauss M, Bartek J. Cyclin D1 protein expression and function in human breast cancers. Int J Cancer 1994; 57: 353-361.
34. Buckley MF, Sweeney KJ, Hamilton JA, et al. Expression and amplification of cyclin genes in human breast cancer. Oncogene 1993; 8: 2127-2133.
35. Naitoh H, Shibata J, Kawaguchi A, Kodama M, Hattori T. Overexpression and localization of cyclin D1 mRNA and antigen in esophageal cancer. Am J Pathol 1995; 146: 1101-1169.
36. Shinozaki H, Ozawa S, Ando N, et al. Cyclin D1 amplification as a new predictive classification for squamous cell carcinoma of the esophagus, adding gene information. Clin Cancer Res 1996; 2: 1141-1161.
37. Gansauge S, Gansauge F, Ramadani M, et al. Overexpression of cyclin D1 in human pancreatic carcinoma is associated with poor prognosis. Cancer Res 1997; 57: 1634-1637.
38. Pagano M, Theodoras AM, Tam SW, Draetta G. Cyclin D1-mediated inhibition of repair and replicative DNA synthesis in human fibroblasts. Genes & Dev 1994; 8: 1627-1639.
39. Matsuoka S, Yamaguchi M, Matsukage A. D-type cyclin-binding regions of proliferating cell nuclear antigen. J Biol Chem 1994; 269: 11030-11036.
40. Xiong Y, Zhang H, Beach D. D type cyclins associate with multiple protein kinases and the DNA replication and repair factor PCNA. Cell 1992; 71: 505-514.
41. Atadja P, Wong H, Veillete C, Riabowol K. Overexpression of cyclin D1 blocks proliferation of normal diploid fibroblasts. Exp Cell Res 1995; 217: 205-216.
42. Garkavtsev I, Hull C, Riabowol. Molecuar aspects of the relationship between cancer and aging: tumor suppressor activity during cellular senescence. Exp Gerontology 1998; 33: 81-94.
43. Dulic V, Drullinger LF, Lee E, Reed SI, Stein GH. Altered regulation of G1 cyclins in senescent human fibroblasts: accumulation of inactive cyclin E-cdk2 and cyclin D1-cdk4 complexes. Proc Natl Acad Sci USA 1993; 90: 11034-11038.
44. Lucibello FC, Sewing A, Brusselbach S, Burger C, Muller R. Deregulation of cyclins D and E and suppression of cdk2 and cdk4 in senescent human fibroblasts. J Cell Sci 1993; 105: 123-133.
45. Dowdy SF, Hinds PW, Louie K, Reed SI, Arnold A, Weinberg RA. Physical interaction of the retinoblastoma protein with human D cyclins. Cell 1993; 73: 499-511.
46. Freeman RS, Estus S, Johnson EM Jr. Analysis of cell cycle-related gene expression in post-mitotic neurons selective induction of cyclin D1 during programmed cell death. Neuron 1994; 12: 343-355.
47. Han EKH, Sgambato A, Jiang W, et al. Stable overexpression of cyclin D1 in a human mammary epithelial cell line prolongs the S-phase and inhibits growth. Oncogene 1995; 10: 953-961.
48. Horiguchi-Yamada J, Yamada H, Nakada S, Ochi K, Nemoto T. Changes of G1 cyclins, cdk2 and cyclin A during the differentiation of HL-60 cells induced by TPA. Mol Cell Biochem 1994; 132: 31-37.
49. Skapek SX, Rhee J, Spicer DB. Lassar AB. Inhibition of myogenic differentiation in proliferating myoblasts by cyclin D1-dependent kinase. Science 1995; 267: 1022-1024.
50. Betticher DC, Thatcher N, Altermatt HJ, Hoban P, Ryder WDJ, Heighway J. Alternate splicing produces a novel cyclin D1 transcript. Oncogene 1995; 11: 1005-1011.
51. Hosokawa Y, Gadd M, Smith AP, Koerner FC, Schmidt EV, Arnold A. Cyclin D1 (PRAD1) alternative transcript b: fulllength cDNA cloning and expression in breast cancers. Cancer Lett 1997; 113: 123-130.
52. Sawa H, Ohshima A, Ukita H, et al. Alterantively spliced forms of cyclin D1 modulate entry into the cell cycle in an inverse manner. Oncogene 1998; 16: 1701-1712.
53. kip1 protein in human esophageal cancer cell line that overexpress cyclin D1. Carcinogenesis 1997; 18: 1139-1148.
54. Lahti JM, Li H, Kidd VJ. Elimination of cyclin D1 in vertebrate cells leads to an altered cell cycle phenotype, which is rescued by overexpression of murine cyclins Dl, D2 or D3 but not by a mutant cyclin D1. J Biol Chem 1997; 272: 10859-10869.
55. Chen X, Bargonetti J, Prives C. p53, through p21 (WAF1/CIP1), induces cyclin D1 synthesis. Cancer Res 1995; 55: 4257-4263.
56. kip1 induces cell cycle arrest and loss of cyclin-cdk activity in human breast cancer cells. Oncogene 1997; 14: 2283-2289.
57. kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 1994; 78: 59-66.
58. Toyoshima H, Hunter T. p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell 1994; 78: 67-74.
59. kip1 for restriction point control of the fibroblast cell cycle. Science 1996; 272: 877-880.
60. Fero ML, Rivkin M, Tasch M, et al. A syndrome of multi-organ hyperplasia with features of gigantism, tumorigenesis, and female sterlity in p27 (Kip1)-deficient mice. Cell 1996; 85: 733-744.
61. Kiyokawa H, Kineman RD, Manova-Todorova KO, et al. Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27 (Kip1). Cell 1996; 85: 721-732.
62. Nakayama K, Ishida N, Shirane M, et al. Mice lacking p27 (Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell 1996; 85: 707-720.
63. kip1. J Clin Invest 1996; 97: 1983-1988.
64. Katayose Y, Kim M, Rakkar ANS, Li Z, Cowan KH, Seth P. Promoting apoptosis: A novel activity associated with the cyclin-dependent kinase inhibitor p27. Cancer Res 1997; 57: 5441-5445.
65. kip1 over-expression causes apoptotic death of mammalian cells. Oncogene 1997; 15: 2991-2997.
66. kip1 with cyclin A-Cdk2 and Cyclin D2-Cdk4. J Biol Chem 1997; 272: 25863-25872.
67. Sgambato A, Han EK, Zhou P, Schieren I, Weinstein I.B. Over-expression of cyclin E in the HC11 mouse mammary epithelial cell line is associated with growth inhibition and increased expression of p27Kip1. Cancer Res 1996; 15: 1389-1399.
68. Field SJ, Tsai FY, Kuo F, et al. E2F-1 functions in mice to promote apoptosis and suppress proliferation. Cell 1996; 85: 549-561.
69. Hunt KK, Deng J, Liu TJ, et al. Adenovirus-mediated over-expression of the transcription factor E2F-1 induces apoptosis in human breast and ovarian carcinoma cell lines and does not require p53. Cancer Res 1997; 57: 4722-4726.
70. Ganter B, Fu SI, Lipsick JS. D-type cyclins repress transcriptional activation by the v-Myb but not the c-Myb DNA-binding domain. EMBO J 1998; 1: 255-268.
71. Shan B, Lee WH. Deregulated expression of E2F-1 induces S-phase entry and leads to apoptosis. Mol Cell Biol 1994; 14: 8166-8173.
72. Hirai H, Sherr CJ. Interaction of D-type cyclins with a novel myb-like transcription factor, DMP1. Mol Cell Biol 1996; 16: 6457-6467.
73. Kazushi I, Sherr CJ. Gene expression and cell cycle arrest mediated by transcription factor DMP1 is antagonized by D-type cyclins through a cyclin-dependent-kinase-independent mechanism. Mol Cell Biol 1998; 18: 1590-1600.
74. Evan G, Littlewood, T. A matter of life and death. Science 1998; 282: 1317-1322.